ZNF169
gene geneOn this page
Also known as MGC51961
Summary
ZNF169 (zinc finger protein 169, HGNC:12957) is a protein-coding gene on chromosome 9q22.32, encoding Zinc finger protein 169 (Q14929). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 169841 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 90 total
- MANE Select transcript:
NM_194320
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12957 |
| Approved symbol | ZNF169 |
| Name | zinc finger protein 169 |
| Location | 9q22.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC51961 |
| Ensembl gene | ENSG00000175787 |
| Ensembl biotype | protein_coding |
| OMIM | 603404 |
| Entrez | 169841 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 9 protein_coding, 1 retained_intron
ENST00000340911, ENST00000395395, ENST00000480716, ENST00000481550, ENST00000492115, ENST00000718459, ENST00000718460, ENST00000873354, ENST00000873355, ENST00000873356
RefSeq mRNA: 3 — MANE Select: NM_194320
NM_001301275, NM_003448, NM_194320
CCDS: CCDS6709
Canonical transcript exons
ENST00000395395 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001421123 | 94299815 | 94301829 |
| ENSE00001853948 | 94259298 | 94259345 |
| ENSE00003548741 | 94292341 | 94292467 |
| ENSE00003616200 | 94278758 | 94278845 |
| ENSE00003672045 | 94292974 | 94293069 |
Expression profiles
Bgee: expression breadth ubiquitous, 219 present calls, max score 89.75.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2778 / max 29.2792, expressed in 1148 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 97453 | 2.2778 | 1148 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 89.75 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.80 | gold quality |
| monocyte | CL:0000576 | 80.21 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 80.14 | gold quality |
| cardia of stomach | UBERON:0001162 | 79.77 | gold quality |
| leukocyte | CL:0000738 | 79.70 | gold quality |
| rectum | UBERON:0001052 | 79.54 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 78.33 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 77.85 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 77.80 | silver quality |
| right uterine tube | UBERON:0001302 | 77.02 | gold quality |
| right ovary | UBERON:0002118 | 76.73 | gold quality |
| left ovary | UBERON:0002119 | 76.58 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 76.41 | gold quality |
| vena cava | UBERON:0004087 | 76.18 | silver quality |
| endocervix | UBERON:0000458 | 76.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.12 | gold quality |
| ventral tegmental area | UBERON:0002691 | 76.08 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 76.03 | gold quality |
| lymph node | UBERON:0000029 | 75.88 | gold quality |
| body of uterus | UBERON:0009853 | 75.77 | gold quality |
| right coronary artery | UBERON:0001625 | 75.65 | gold quality |
| tibial nerve | UBERON:0001323 | 75.58 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 75.48 | gold quality |
| trachea | UBERON:0003126 | 75.48 | gold quality |
| transverse colon | UBERON:0001157 | 75.44 | gold quality |
| ectocervix | UBERON:0012249 | 75.41 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 75.35 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 75.26 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.99 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
14 targeting ZNF169, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-154-5P | 98.92 | 66.65 | 733 |
| HSA-MIR-1245B-5P | 98.88 | 66.55 | 576 |
| HSA-MIR-3142 | 98.88 | 66.09 | 529 |
| HSA-MIR-3611 | 98.76 | 68.76 | 1290 |
| HSA-MIR-4733-3P | 98.35 | 65.20 | 994 |
| HSA-MIR-6849-3P | 97.25 | 64.57 | 1371 |
Literature-anchored findings (GeneRIF, showing 1)
- Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1. (PMID:38666541)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp169 | ENSMUSG00000050954 |
| rattus_norvegicus | Zfp169 | ENSRNOG00000017092 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 169 — Q14929 (reviewed: Q14929)
All UniProt accessions (4): Q14929, Q5SR55, Q7Z761, S4R440
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in kidney, weakly expressed in heart, liver, spleen, and small intestine. Not expressed in adult brain or spinal cord.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001288204, NP_003439, NP_919301* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (30 total): zinc finger region 13, sequence conflict 7, sequence variant 5, region of interest 2, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14929-F1 | 72.11 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 54 (showing top):
chr9q22, URS_ADIPOCYTE_DIFFERENTIATION_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, DLX4_TARGET_GENES, DMRT1_TARGET_GENES, ELF2_TARGET_GENES, FEV_TARGET_GENES, PAX3_TARGET_GENES, SUPT16H_TARGET_GENES, ZSCAN2_TARGET_GENES, MIR3941, MIR6876_5P, MIR4476
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
628 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF169 | ASS1 | P00966 | 750 |
| ZNF169 | FANCC | Q00597 | 624 |
| ZNF169 | XPA | P23025 | 581 |
| ZNF169 | TGFBR1 | P36897 | 574 |
| ZNF169 | PTCH1 | Q13635 | 529 |
| ZNF169 | ATP13A4 | Q4VNC1 | 508 |
| ZNF169 | NUTM2G | Q5VZR2 | 473 |
| ZNF169 | SLC67A1 | Q96BI1 | 457 |
| ZNF169 | GJA10 | Q969M2 | 452 |
| ZNF169 | SLC38A4 | Q969I6 | 449 |
| ZNF169 | HHAT | Q5VTY9 | 449 |
| ZNF169 | NUTM2F | A1L443 | 448 |
| ZNF169 | CFAP210 | Q0VFZ6 | 448 |
| ZNF169 | DUSP22 | Q9NRW4 | 441 |
| ZNF169 | AGPAT2 | O15120 | 432 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCNDBP1 | ZNF169 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF169 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF169 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | CABP5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF169 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CABP5 | ZNF169 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (85): ZNF169 (Two-hybrid), ZNF169 (Two-hybrid), KRTAP10-7 (Two-hybrid), ZNF169 (Affinity Capture-MS), C10orf2 (Affinity Capture-MS), RBAK (Affinity Capture-MS), SOGA1 (Affinity Capture-MS), ZYG11A (Affinity Capture-MS), ZNF92 (Affinity Capture-MS), SORL1 (Affinity Capture-MS), ZNF689 (Affinity Capture-MS), ZBTB10 (Affinity Capture-MS), ZNF445 (Affinity Capture-MS), TRIM41 (Affinity Capture-MS), TRIM26 (Affinity Capture-MS)
ESM2 similar proteins: A3KN32, A3KN36, O14709, O43296, O75123, P15622, P16373, P17023, P17031, P17097, P52736, P85977, Q07230, Q12901, Q14929, Q29RZ4, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RBX0, Q5RBY9, Q5RCD9, Q5RCX4, Q61751, Q61967, Q6GQR8, Q6IV72, Q6NX45, Q6PK81, Q6ZMS4, Q7TNU6, Q7TSH9, Q7Z398, Q7Z7L9, Q8BI99, Q8BIQ3, Q8BLB0, Q8IZ26
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
819 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:94278754:CCAG:C | acceptor_loss | 1.0000 |
| 9:94278757:GATTT:G | acceptor_gain | 1.0000 |
| 9:94278842:GGAG:G | donor_gain | 1.0000 |
| 9:94278843:GAG:G | donor_gain | 1.0000 |
| 9:94278843:GAGG:G | donor_gain | 1.0000 |
| 9:94278844:AGGTA:A | donor_loss | 1.0000 |
| 9:94278845:GGTA:G | donor_loss | 1.0000 |
| 9:94278846:G:GA | donor_loss | 1.0000 |
| 9:94278846:G:GG | donor_gain | 1.0000 |
| 9:94278847:T:A | donor_loss | 1.0000 |
| 9:94292335:TTACA:T | acceptor_loss | 1.0000 |
| 9:94292339:A:AG | acceptor_gain | 1.0000 |
| 9:94292339:AG:A | acceptor_gain | 1.0000 |
| 9:94292340:G:GT | acceptor_gain | 1.0000 |
| 9:94292340:GG:G | acceptor_gain | 1.0000 |
| 9:94292340:GGC:G | acceptor_gain | 1.0000 |
| 9:94292340:GGCA:G | acceptor_gain | 1.0000 |
| 9:94292340:GGCAT:G | acceptor_gain | 1.0000 |
| 9:94292428:G:T | donor_gain | 1.0000 |
| 9:94292434:A:AG | donor_gain | 1.0000 |
| 9:94292466:GG:G | donor_gain | 1.0000 |
| 9:94292467:GG:G | donor_gain | 1.0000 |
| 9:94292468:G:A | donor_loss | 1.0000 |
| 9:94292468:G:GG | donor_gain | 1.0000 |
| 9:94292469:T:G | donor_loss | 1.0000 |
| 9:94292965:T:TA | acceptor_gain | 1.0000 |
| 9:94292967:T:TA | acceptor_gain | 1.0000 |
| 9:94292971:TAGGA:T | acceptor_loss | 1.0000 |
| 9:94292972:A:G | acceptor_loss | 1.0000 |
| 9:94292973:G:GT | acceptor_loss | 1.0000 |
AlphaMissense
3953 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:94300537:T:C | F327L | 0.999 |
| 9:94300539:T:A | F327L | 0.999 |
| 9:94300539:T:G | F327L | 0.999 |
| 9:94300621:T:C | F355L | 0.999 |
| 9:94300623:T:A | F355L | 0.999 |
| 9:94300623:T:G | F355L | 0.999 |
| 9:94300873:T:C | F439L | 0.999 |
| 9:94300875:T:A | F439L | 0.999 |
| 9:94300875:T:G | F439L | 0.999 |
| 9:94300957:T:C | F467L | 0.999 |
| 9:94300959:T:A | F467L | 0.999 |
| 9:94300959:T:G | F467L | 0.999 |
| 9:94300369:T:C | F271L | 0.997 |
| 9:94300371:T:A | F271L | 0.997 |
| 9:94300371:T:G | F271L | 0.997 |
| 9:94300453:T:C | F299L | 0.997 |
| 9:94300455:C:A | F299L | 0.997 |
| 9:94300455:C:G | F299L | 0.997 |
| 9:94300789:T:C | F411L | 0.997 |
| 9:94300791:T:A | F411L | 0.997 |
| 9:94300791:T:G | F411L | 0.997 |
| 9:94300874:T:C | F439S | 0.997 |
| 9:94300538:T:C | F327S | 0.996 |
| 9:94300705:T:C | F383L | 0.996 |
| 9:94300707:C:A | F383L | 0.996 |
| 9:94300707:C:G | F383L | 0.996 |
| 9:94300734:C:A | H392Q | 0.996 |
| 9:94300734:C:G | H392Q | 0.996 |
| 9:94300892:T:C | L445P | 0.996 |
| 9:94300902:C:A | H448Q | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000223284 (9:94269146 T>C), RS1000264404 (9:94260982 G>A), RS1000273346 (9:94276580 A>G), RS1000488597 (9:94282226 T>G), RS1000506612 (9:94268206 A>G), RS1000607420 (9:94274864 C>T), RS1000698369 (9:94260711 G>A), RS1000737627 (9:94273984 A>C), RS1000744311 (9:94277718 T>G), RS1000845877 (9:94298685 C>T), RS1000874510 (9:94263089 T>A,C), RS1000938007 (9:94293937 G>A), RS1001024954 (9:94273780 C>T), RS1001038723 (9:94294443 GA>G,GAA), RS1001137898 (9:94258123 C>G,T)
Disease associations
OMIM: gene MIM:603404 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001416_9 | Body mass index (SNP x SNP interaction) | 6.000000e-07 |
| GCST004904_45 | Body mass index | 3.000000e-09 |
| GCST004904_63 | Body mass index | 2.000000e-09 |
| GCST006222_3 | Cerebellum growth | 1.000000e-06 |
| GCST008128_5 | Body mass index | 9.000000e-10 |
| GCST009379_90 | Type 2 diabetes | 2.000000e-09 |
| GCST009379_91 | Type 2 diabetes | 3.000000e-06 |
| GCST90002396_410 | Mean reticulocyte volume | 4.000000e-29 |
| GCST90002397_687 | Mean spheric corpuscular volume | 3.000000e-13 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0010701 | mean reticulocyte volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression, increases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | decreases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW11 | HEK293 eGFP-ZNF169 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.